ro 31-8830 has been researched along with Anasarca in 1 studies
Ro 31-8830: structure given in first source; derivative of Ro 31-8425 with in vivo anti-inflammatory activity
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mulqueen, MJ | 1 |
| Bradshaw, D | 1 |
| Davis, PD | 1 |
| Elliott, L | 1 |
| Griffiths, TA | 1 |
| Hill, CH | 1 |
| Kumar, H | 1 |
| Lawton, G | 1 |
| Nixon, JS | 1 |
| Sedgwick, AD | 1 |
1 other study available for ro 31-8830 and Anasarca
| Article | Year |
|---|---|
Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cattle; CD3 | 1992 |